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ABSTRACT 
Objective We assessed the diagnostic accuracy of POC-CCA test for schistosome infections using 
Kato-Katz technique (for Schistosoma mansoni and S. japonicum) or 10 mL urine filtration (for S. 
haematobium) as reference. 
Methods We searched MEDLINE, EMBASE and LILACS to 30th September 2014, updated  to 30th 
September 2015, as well as the Cochrane Library, reference lists and grey literature, and we contacted 
experts for unpublished studies.  Twenty-seven published studies (1994-2014) met the inclusion 
criteria and were presented as sensitivity and specificity with 95 % CIs. Latent class bivariate 
modelling (LCBM) captured the between-study test variability. 
Findings Single POC-CCA performed better than single Kato-Katz test (pooled sensitivity 0.90, 95% 
CI 0.84-0.94 and specificity 0.56, 95% CI 0.54-0.61; n=7) or three Kato-Katz tests (sensitivity 0.85, 
95% CI 0.80-0.88 and specificity 0.66, 95% CI 0.54-0.76; n=14) for detecting S. mansoni. Accuracy 
from area under the ROC curve of single POC-CCA versus single Kato-Katz was 0.86. There is no 
demonstrable advantage of three over single CCA tests. LCBM identified two POC-CCA classes. 
Sensitivity analyses showed that the results were not strongly influenced by any particular study. Both 
CCA sensitivity and specificity appeared to be poor for S. haematobium. No studies were found for S. 
japonicum. POC-CCA performed better in high than low endemicity settings, and participants consid-
ered the urine-based POC-CCA acceptable, but data on comparative costs of applying POC-CCA and 
Kato-Katz is scarce. 
Conclusion POC-CCA test may represent an effective tool for monitoring and evaluation of S. 
mansoni control programmes, but the evidence for other schistosome infections is inconclusive. 
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BACKGROUND 
Schistosomiasis, caused by a group of flat worms that reside in the blood vessels in humans, is 
common among low income countries in the tropical and sub-tropical regions whose health systems 
face difficulties to provide basic care at the peripheral level.1 An estimated 800 million people are at 
risk of the infection and over 207 million have the infection.2-5 A person with schistosomiasis may be 
re-infected repeatedly even when regular treatment is provided6-7, necessitating repeated screening 
and treatment in endemic populations. Five species, namely Schistosoma mansoni, S. haematobium, S. 
japonicum, S. intercalatum and S. mekongi can infect humans, but the three with significant public 
health impact are S. mansoni (common in Africa and some countries in South America), S. 
haematobium (endemic in Africa and the Middle East) and S. japonicum (mainly found in the 
People’s Republic of China, Lao and the Philippines).5  S. mansoni and S. japonicum cause intestinal 
schistosomiasis whilst S. haematobium causes urogenital schistosomiasis. 
 
The WHO strategy for schistosomiasis control over the years has been active case detection and 
treatment with praziquantel (PZQ). Mass treatment with no prior diagnosis is usually employed in 
high endemicity settings.5 For intestinal schistosomiasis, Kato-Katz thick smear8 is the recommended 
diagnostic technique because of its assumed sensitivity, ability to classify intensity of infection, ease 
of use in the field and low cost whereas the standard 10 mL filtration of urine is used for urogenital 
schistosomiasis. Sensitivity of both the Kato-Katz and urine filtration depends on severity of the 
infection, and in low grade infections, sensitivity may be well below 30%.9-10 For Kato-Katz test, for 
example, several stool specimens collected on different days are required to increase sensitivity.   
 
Prevalence and intensity of infection have fallen significantly in most endemic areas following the 
introduction of mass drug administration (MDA) within the preventive chemotherapy (PC) strategy5. 
The routinely used diagnostic tests are no longer sensitive. Therefore, sensitive and easy-to-use at low 
cost diagnostic test is a necessity. Schistosomes release secretory metabolites identified as 
Schistosoma-genus specific circulatory antigens namely circulatory anodic antigen (CAA) and 
circulatory cathodic antigen (CCA)11-13 linked with active infections14 have been independently 
evaluated.15-18. Further research on CCA has produced the Point-Of-Care (POC) urine-based cassette 
assay19 which has been validated in settings in Africa and that it is much more sensitive than the Kato-
Katz test, even though it appears to suffer the same limitation when intensities of infection are low.20-
24.  Sensitivity of POC-CCA for urinary schistosomiasis has been variable in the few studies that have 
evaluated this.19 
 
Given that systematic reviews are widely regarded as providing the best evidence to inform healthcare 
decisions25-26, the WHO commissioned this review to assess the diagnostic accuracy of CCA test in a 
systematic review and meta-analysis to inform its control policy. Recently a Cochrane review has 
been published on this subject.27   
This review was conducted with the primary objective to assess diagnostic accuracy of POC-CCA test 
for the diagnosis of schistosome infections using stool-based Kato-Katz thick smear (for S. mansoni 
and S. japonicum,) or standard 10 mL urine filtration (for S. haematobium) as reference standard. The 
secondary objectives were to assess the performance of ELISA for CCA in serum or urine, or other 
CCA assays and cost of field application of POC-CCA as well as effect of geographic location, age, 
endemicity and prior treatment on the performance of CCA. The study also compared time required 
for preparation and application; and user preference for POC-CCA versus Kato-Katz test and the 
standard 10 mL urine filtration method.  
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CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW  
Eligibility standard forms based on predefined inclusion criteria were used to retrieve, select and 
assess quality of the studies. 
  
Types of studies 
Any study that compared CCA test with a reference standard (Kato-Katz or urine filtration, or both) 
for the diagnosis of schistosome infection; where precontrol infection status of the participants was 
not known; tests were performed in the same participants, and reported true-positives (TP, defined as 
individuals with infection who tested positive), true-negatives (TN, defined as those who did not have 
infection and tested negative), false-positives (FP, defined as individuals without infection who tested 
positive), and false-negatives (FN, defined as individuals with infection but tested negative) or where 
these could be extracted, were eligible for inclusion. 
 
Types of participants  
Individuals diagnosed microscopically for the presence of schistosome eggs in their stool (for S. 
mansoni and S. japonicum) using the Kato-Katz technique as reference standard8 or in their urine 
using the standard 10 mL urine filtration method (for urogenital schistosomiasis).  
 
Diagnostic thresholds 
We used the commonly applied classification of intensity thresholds for Kato-Katz and the standard 
10mL urine filtration tests based on WHO classification to define intensity of infection for interpret-
ing our data. For Kato-Katz, this has been defined as “light infection” (< 100 EPG), “moderate infec-
tion” (100-399 EPG) and “heavy infection” (≥ 400 EPG) and for the standard 10 mL urine filtration 
test, “light infection” (≤ 50 eggs/10mL of urine) and “heavy infection” (> 50 eggs/10 mL of urine)”. 
For POC-CCA we followed the manufacturer’s definition classifying qualitatively as “trace as nega-
tive” (-), “trace as positive” (tr), “single positive” (+), “double positive” (++) and “triple positive” 
(+++). 
 
REVIEW METHODS 
Search methods for identification of studies  
We searched MEDLINE, EMBASE and LILACS from inception to 30th September 2014, updated on 
30th September 2015, using various search terms with no language restriction. We also searched 
BIOSIS, Web of Science, Google Scholar, Rapid Medical Diagnostics database, African Journals 
Online, Cochrane Infectious Diseases Group Specialized Register, CENTRAL (The Cochrane Library 
2014 and updated in 2015) and mRCT. As accuracy studies present with lack of suitable 
methodological search filters, we maximised sensitivity of our search by using free texts based on the 
index test and target condition. We also hand-checked the reference lists of relevant articles and 
textbooks, and contacted experts for unpublished studies.  
 
Selection of studies 
One author searched the literature and retrieved studies using the aforementioned search strategy. 
Two authors screened the results to identify potentially relevant studies.  Full study reports were 
obtained and assessed for eligibility for inclusion in the review using eligibility form based on the 
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predefined inclusion criteria. Twenty-seven studies published between 1994 and 2014 met the 
inclusion criteria. Any discrepancies were resolved through discussion between the authors.  
 
Data extraction and management  
Study characteristics such as citation, country and year study was conducted, study design and meth-
ods were recorded on standard forms. Information on diagnostic criteria of the index test and refer-
ence standard as well as number of urine samples tested and threshold classification  was extracted. 
For Kato-Katz technique, data extracted included number of stool samples and  slides, and volume of 
stool examined as well as how intensity of infection was classified (low, moderate and high). For 
urine specimens, information about number of urine specimens, and intensity categorization (low and 
high) were extracted. We extracted epidemiological and demographic data including endemicity sta-
tus, region where the study was conducted, participants’ prior treatment status, target population (pre-
school children, school-aged children, adults, whole population or representative sub-samples), sex 
and age, and study size. We also extracted information on cost of test, level of training and experience 
of technicians, and whether diagnosis was delivered at point of care.  
 
We extracted TP, FP, TN and FN needed to populate the 2 x 2 tables. Authors of primary studies were 
contacted for unclear or insufficient data. Where possible, we obtained raw data from primary study 
authors to calculate values needed to populate the 2 x 2 contingency table. For studies that provided 
categorical data based on intensity of infection, we extracted numbers of index test positive and nega-
tive participants using the aforementioned thresholds. If two or more communities were involved in 
the study, data were extracted for each community, with a link to the parent study. Two authors ex-
tracted data using a pre-tested data extraction form and cross-checked for errors. Disagreements were 
resolved through discussion. 
 
Data synthesis 
Data were analysed and presented as sensitivity, specificity and false positive rate, with their 95 % 
confidence intervals (CI). The meta-analyses were performed using the bivariate model specified in 
Reitsma (2005)28, using the Mada package in the R programming environment.29 A continuity 
correction of 0.5 was added to all cell values. The function fits the bivariate model described by 
Reitsma28 that Habord (2007)30 showed to be equivalent to the Hierarchical Summary Receiver 
Operating Characteristics (HSROC) by Rutter (2001).31 We specified the model as a linear mixed 
model with known variances of the random effects, similar to the computational approach by Reitsma 
(2005).28 Variance components are estimated by restricted maximum likelihood (REML). In addition 
meta-regression is possible and the use of other transformations than the logit, using the approach of 
Doebler (2015).29 The bivariate meta-regression was conducted using random effects approach 
incorporating the amount of correlation between sensitivity and specificity across studies. A p-value 
below 0.05 was used to test statistical significance. In order to remove the need to adjust for 
confounders, the analysis was restricted to studies that evaluated both index and reference standard 
tests in the same patients. Sub-group effects were investigated by stratifying the analyses by age 
(preschool children and infants, school- aged children and adults), sensitivity of reference standard 
and background endemicity measured by prevalence of the infection: low, moderate and high (for 
intestinal schistosomiasis) and low and high (for urinary schistosomiasis). 
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Assessment of heterogeneity and sub-group analysis 
We assessed heterogeneity by inspecting the forest plots for overlapping CIs and outlying data; using 
the Chi-squared  test with a p-value < 0.10 to indicate statistically significant heterogeneity based on 
commonly accepted DerSimonian & Laird test32 that uses a more sensitive threshold of p < 0.10. The 
Cochrane collaboration recommends the use of p-value < 0.10 in statistical testing of heterogeneity in 
accuracy tests.33 Therefore, we followed this convention, by defining heterogeneity as significant 
when p < 0.10 rather than the conventional level of p-value < 0.05. Where significant heterogeneity 
was detected, we carried out subgroup analyses based on clinical and methodological differences..  
 
We applied an exploratory analysis34 to investigate the performance of POC-CCA test with Kato-Katz 
as reference standard  by means of a Latent Class Bivariate Model (LCBM). LCBM using Latent 
GOLD v 5.035 was fitted to capture the between-study variability in sensitivity and specificity by as-
suming that studies belong to one of several latent classes. Number of latent classes was selected us-
ing Akaike Information Criterion (AIC). This yielded both an interpretation and a description of the 
heterogeneity between studies.34 
 
RESULTS 
Of the 4,578 records retrieved by the search, twenty seven studies reported in 21 published papers met 
the inclusion criteria (Fig. 1 Flow diagram and Table 1 Summary of the characteristics of the included 
studies).  
 
The studies were all conducted in Africa, 13 in East Africa23,24, 36-46 six in West Africa15-17,20,47-48 and 
one study in Southern Africa.49   No study has been conducted in Central or North Africa and one 
study22 was not assigned a specific country. Three of the studies were conducted in the 1990s and 
used the older version of CCA15-17, the rest were conducted after the new millennium. None of the 
studies was a randomized control trial (RCT). Twenty-five studies assessed CCA for the diagnosis of 
S. mansoni and two for S. haematobium, and none for S. japonicum.  
 
Two publications20,48 that reported studies conducted in low, moderate and high endemicity settings 
were each managed as three separate studies. One study39 that assessed adults and children and 
reported data separately was managed as two study-data points. One publication22 was included 
because it reported primary data of a five-country study some of which were not available in the 
individual country studies. Some authors who were contacted provided additional data.23, 24, 44 
 
POC-CCA VERSUS KATO-KATZ  
a) Single POC-CCA versus single Kato-Katz  
The accuracy of single POC-CCA test compared to single Kato-Katz reference standard (41.7 mg 
duplicate slides) for the detection of S. mansoni infection was investigated by seven 
studies20,21,23,24,38,42,44, from Kenya, Cameroon, Cote d'Ivoire, Uganda, Ethiopia, Kenya and Uganda, 
respectively. The meta-analysis showed sensitivity of POC-CCA test to be high [0.90, 95% CI 0.84-
0.94, n=7] but low specificity [0.56, 95% CI 0.54-0.61, n=7] (Fig. 2). Analysing based on a summary 
of ROC showed diagnostic accuracy measured by area under curve (AUC) of 0.86 (Fig. 3). Clearly, 
there is wide variation in the false positive rate of POC-CCA for detecting S. mansoni infection as 
depicted by the individual eclipses under the ROC space. 
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b) Single POC-CCA versus three KATO-KATZ 
Fourteen studies published in nine papers20,21,24,32,38-41,47 compared single POC-CCA test with Kato-
Katz test from three consecutive stools (41.7 mg duplicate) for the detection of S. mansoni infection 
and showed sensitivity of 0.85 [95% CI 0.80-0.88, n=14] and specificity 0.66 [95% CI 0.54-0.76, 
n=14]. The CIs of some of the studies were wide, suggesting small sample sizes. Whilst sensitiity 
estimates showed some consistency, there was huge variation in specificity in POC-CCA test. 
 
For the rest of the analyses and results see Appendix. 
 
 
DISCUSSION 
This systematic review assessed  accuracy of urine-based POC-CCA cassette test for the diagnosis of 
schistosome infections using stool-based Kato-Katz thick smear (for S. mansoni and S. japonicum,) or 
standard 10 mL urine filtration (for urinary schistosomiasis) as reference standard. The key findings 
show that single POC-CCA performs better than single Kato-Katz (duplicate 41.7 mg of stool).  
 
Although most of the studies included in this review were conducted recently, after the new 
millennium, methodological quality did not reach expected standards. For example, none of the 
studies was RCT. Notwithstanding, given that the results have been consistent across studies and 
sensitivity analysis establishing that the results are robust to changes, as well as an independent 
study50 showing no batch-to-batch variation with POC-CCA, negligible intra-reader variability (2%), 
and substantial agreement for inter-reader reliability of the test, it is unlikely that methodological 
quality will have caused substantial bias to affect the evidence presented.  
 
All the studies were conducted in Africa, mostly from East Africa. Twenty five studies assessed POC-
CCA for the diagnosis of S. mansoni infection and two for urogenital schistosomiasis with the 
majority involving children (preschool and school children). None of the studies assessed POC-CCA 
in the Americas (for the detection of S. mansoni) or Asia (for S. japonicum infection).  Although this 
is not expected to affect generalizability of the review’s conclusions, studies in other endemic settings 
or involving other schistosome species such as S. mekongi and S. intercalatum should be 
encouraged.51  
 
The finding that CCA performs better in high compared to low endemicity settings has both practice 
and control implications as it suggests that CCA may not have an advantage over routinely used 
diagnostic tests which are being replaced. The lack of a true gold standard (i.e. a diagnostic test of 100 
% specificity and 100 % sensitivity) a major problem for reliably assessing specificity of new tools is 
probably to be blamed for this observation.  Therefore, to evaluate a new test, microscopy has to be 
performed on multiple samples in order to create a reliable ‘parasitological gold standard’.52 However, 
given the limitations of microscopy, combining the index test and the reference standard (considered 
to have higher sensitivity than the index test or the reference standard alone) with an individual 
considered to have the infection if positive for either Kato-Katz or CCA in the combined reference 
standard may be the best way of creating a ‘true’ gold standard.52  
 
Although sensitivity and specificity of POC-CCA improve when assessed against an ‘assumed gold 
standard’ that combines the index test and reference standard,52 comparing CCA versus combined 
CCA/Kato-Katz is far from ideal given that CCA test may add false positives (and negatives) and 
Kato-Katz will certainly add false negatives. Also, there is a possible interdependence or 
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measurement error effect and that the combination is not likely to present a real gold standard. An 
ideal situation would be to have different gold standards for sensitivity and specificity of CCA. For 
sensitivity, the gold standard would be several repeated Kato-Katz slides, ideally collected on 
different days. This is because the likelihood of a false positive result is limited with Kato-Katz given 
that eggs are not easily confused in faeces or urine. An alternative approach would be to use a 
‘predicted’ gold standard at the population level (i.e. the pocket chart.53). For specificity of CCA, the 
best gold standard would be to use negative controls, i.e. persons from non-endemic areas. However, 
we did not retrieve any study that used negative controls.   
  
There may be economies of scale in using combined gold standard tests, the cost of both tests may be 
less than the sum of the cost of either test in isolation. As this review attempted to explore all options 
regarding CCA test, we considered combined Kato-Katz/CCA as a distinct diagnostic test. Some 
primary studies presented the results for combined tests49,54-56 implying that the authors of these 
studies considered the combined Kato-Katz/CCA option to be distinct. Although the combined Kato-
Katz/CCA is not being employed in current control programmes, it is important to assess accuracy as 
this can become a diagnostic option in the future.  
 
The absence of a clear reference standard creates an additional form of uncertainty in  diagnostic test 
meta-analysis. Therefore, we investigated heterogeneity patterns through Latent Class Bivariate 
Analysis34 that identified two latent classes using AIC and BIC criteria that demonstrated a substantial 
difference in diagnostic accuracy which could not be explained just by an implicit or explicit 
threshold effect. Subgroup analyses were needed and the results showed that number of urine samples 
for the test did not affect sensitivity and specificity in POC-CCA appreciably. Further exploratory 
analysis involving compilation of studies classified into latent classes was conducted to relate latent 
class to background factors. The results suggested that the number of urines, year the study was 
conducted and geographic location do not appear to affect accuracy. Age, endemicity and effect of 
treatment could not be thoroughly explored at this stage warranting further studies.  
 
Predictive values are mathematically dependent on the pre-test prevalence of the infection.33,34 Given 
that studies from different endemicity settings were combined in the meta-analysis, pooled sensitivity 
and specificty which are not usually affected by background prevalence were mostly used for 
presenting accuracy or test performance in this review. Nonetheless, sensitivity and specificity vary 
with threshold.   
It is well known that after population-based treatment, most individuals not fully cured will have light 
infections, which can easily be missed by insensitive tests. The main purpose to evaluate POC-CCA 
after treatment would be to assess whether the test can pick up light infections. In our review we 
evaluated the effect of endemicity (i.e. light versus moderate/heavy infection) with the specific aim to 
gain knowledge about how the test would perform under real situations of low intensity of infection. 
Crudely speaking, moderate/heavy infections represent pre-control situations and light infections 
represent post-control. We believe that our approach for not including post-treatment data does not 
represent a serious limitation or a major drawback, but we appreciate the fact that important additional 
evidence would have come from real post treatment studies, if they were available, to compare post-
treatment test performances with that of pre-control light infections. In fact, a bias could be introduced 
when doing test assessment after treatment, as the status of infection is already known. 
Notwithstanding, there may always be unknown confounding factors that we could not account for. 
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We have performed meta-analyses and subgroup analyses with few studies and are concerned about a 
risk of false reassurance. Given this problem, we caution the interpretation of the data due to 
incompleteness and false reassurance. Although there are limitations in the studies included in the 
review, the evidence presented appears to be strong and consistent. All the studies were based on fully 
paired (within-study) comparative accuracy studies and this review addressed a well-defined question 
in terms of participants, interventions, outcomes, and study design. The search included relevant 
electronic databases, and attempts were made to retrieve unpublished studies. Bias and errors were 
minimised during the review process with two reviewers independently selecting studies and 
extracting data, and presenting characteristics of the individual studies. Although formal assessment 
of quality of the included studies could not be done as part of this analysis, potential sources of 
heterogeneity were explored and reported. The review conclusions are consistent with the set 
objectives and evidence shown and are likely to be reliable. 
 
Conclusions  
POC-CCA test may represent an effective tool for mapping, monitoring and evaluation of S. mansoni 
control programmes given that it is more sensitive than the Kato-Katz test, commercially available 
and easy-to-use at low cost, but the evidence for S. haematobium may be inconclusive as it comes 
from only two studies. Whilst cost of test appears to be similar between POC-CCA and Kato-Katz 
(based on limited data), it takes relatively shorter time to prepare POC-CCA than Kato-Katz thick 
smear. Well design studies making head-to-head comparisons of cost of application of POC-CCA and 
evaluating effect of treatment are warranted to contribute additional evidence. 
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Table 1 Summary of characteristics of included studies in the systematic review and meta-analysis 
Sr.  
No 
Study*  Country  Trial 
conducted 
N** Sample 
size 
Characteristics 
of participants 
Endemicity ***  Diagnostic criteria Diagnosis at 
POC? 
Trace as 
positive 
Cost of test Acceptabil
ity of test 
Time for CCA 
preparation 
1 Adriko 
201424 
Uganda Not 
reported 
5 500 School children 
7–13 yrs 
8%, 23% & 36% 
for low, moderate 
and high 
endemicity 
settings, 
respectively 
Index test: POC-CCA cassette (single urine) 
Alternative version CCA2 
 
Reference standard: Kato-Katz (one, two, 
three stools, each  41.7 mg duplicate)  
Yes  Both trace as 
+ve and trace 
as -ve 
1.75 USD, 
cited from 
Colley 2013 
Yes  Kato-Katz 
60 min 
POC-CCA 
5-20 min 
2 Colley 
201322 
Cameroon, 
Cote 
d’Ivoire, 
Ethiopia, 
Kenya, 
Uganda 
2010 5 4305 School children, 
9-12 yrs 
15.1%, 25%, 
38.4%, 43%, 47.9 
for the different 
settings in the 
five countries 
Index test: POC-CCA cassette (single urine)  
 
Reference standard: Kato-Katz (one stool, 
41.7 mg duplicate) 
No, 
laboratory 
Yes  Not reported  Yes  Not reported  
3 Coulibaly 
201347 
Cote 
d’Ivoire 
2011 2 242 (156 
children 
dropout) 
Preschool 
children <6 yrs 
 
23.1% Index test: POC-CCA cassette (two urines)  
 
Reference standard: Kato-Katz (two stools, 
41.7 mg duplicate) 
No, 
laboratory 
Both trace a  
+ve and trac  
as -ve  
Single 
POC-CCA 
(US$ 1.75) 
 
Single Kato-
Katz (US$ 1.7) 
Yes  
  
POC-CCA 
25 min 
 
Kato-Katz several 
hours 
4 Dawson 
201332 
Uganda 2011 Not 
reported 
82 Preschool children 
< 6 yrs  
46 children <3 
yrs and 42 
children 3-5 yrs 
45%  Index test: POC-CCA cassette (one urine) 
 
Reference standard: Kato-Katz  (two stools, 
41.7 mg duplicate) 
 
Yes  Yes  Not reported Not 
reported 
Kato-Katz 
30 min 
5 Erko 201338 Ethiopia  2010/2011 2 620 School children: 8-
12 yrs 
34% Index test: POC-CCA cassette (one, two, 
three urines) 
 
Reference standard: Kato-Katz (one, two, 
three stools, 41.7 mg duplicate) 
 
Gold standard: Combined POC-CCA cassette 
(three urines) and Kato-Katz (three stools, 
41.7 mg duplicate) 
No, 
laboratory 
Yes  Not reported  Yes  Not reported 
6 Koukounari 
201339 
Uganda 2005 1 446 Children 7-16 yrs 
and adults 17-76 
yrs 
Not reported  Index test: POC-CCA cassette urine assays 
(25 mL of urine).  
 
Reference standard: Kato-Katz (three stools, 
duplicate) 
No, 
laboratory 
Yes  Not reported Yes  Not reported  
7 Sousa-
Figueiredo 
2013-study 
123 
Uganda 2009 Not 
reported 
333 Preschool children 
≤6 yrs 
7.2% Index test: POC-CCA dipstick test (50 μl) 
 
Reference standard: Kato-Katz (one stool, 
41.7 duplicate) 
 
Gold standard: SEA-ELISA (commercially 
available ELISA test), 75 ml of finger-prick blood 
No, 
laboratory 
Both trace as 
+ve and trace 
as –ve were 
reported 
Not reported  Yes  Not reported 
* Studies published in the same paper have been linked with the parent paper  
**N= number of communities involved in the study  
***Baseline prevalence of the infection according reference standard test.  
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Table 1 cont`d. 
Sr.  
No 
Study  Country  Trial 
conducted 
N* Sample 
size 
Characteristics of 
participants 
Endemicity **  Diagnostic criteria Diagnosis at 
POC? 
Trace as 
positive 
Cost of test Acceptabil
ity of test 
Time for CCA 
preparation 
8 Sousa-
Figueiredo 
2013-study 
223 
Uganda 2009 Not 
reported 
337 Preschool children 
≤6 yrs 
16.9% Index test: POC-CCA dipstick test (50 μl) 
 
Reference standard: Kato-Katz (one stool, 
41.7 duplicate) 
  
Gold standard: SEA-ELISA, 75 ml of finger-
prick blood 
No, 
laboratory 
Both trace as 
+ve and trace 
as –ve were 
reported 
Not reported Yes  Not reported  
9 Sousa-
Figueiredo 
2013-study 
323 
Uganda 2009 Not 
reported  
255 Preschool children 
≤6 yrs 
38.8% Index test: CCA dipstick test (50 μl) 
 
Reference standard: Kato-Katz (one stool, 
41.7 duplicate) 
  
Gold standard: SEA-ELISA (commercially 
available ELISA test), 75 ml of finger-prick 
blood 
No, 
laboratory 
Both trace as 
+ve and trace 
as –ve were 
reported 
Not reported Yes  Not reported  
10 Tchuem 
Tchuente 
2012-study 
121 
Cameroon  2010/2011 1 765 School children 8–
12 yrs 
21%  Index test: POC-CCA cassette (one urine), 
CCA dipstick (designated CCA-L)  
 
Reference standard: Kato-Katz (three stools, 
41.7 mg triplicate) 
 
No, 
laboratory 
Yes  Not reported  Yes  Not reported  
11 Tchuem 
Tchuente 
2012-study 
221 
Cameroon  2010/2011 1 -- School children 8–
12 yrs 
41.8%  Index test: POC-CCA cassette (one urine), 
CCA dipstick (designated CCA-L)  
 
Reference standard: Kato-Katz (three stools, 
41.7 mg triplicate) 
No, 
laboratory 
Yes  Not reported  Yes  Not reported  
12 Tchuem 
Tchuente 
2012-study 
321 
Cameroon  2010/2011 1 -- School children 8–
12 yrs 
31.4%  Index test: POC-CCA cassette (one urine), 
CCA dipstick (designated CCA-L)  
 
Reference standard: Kato-Katz (three stools, 
41.7 mg triplicate) 
No, 
laboratory 
Yes  Not reported  Yes  Not reported  
13 Coulibaly 
2011-study 
120 
Cote 
d’Ivoire 
2010 1 146 Children 8-12 yrs  32.91%, Index test: POC-CCA cassette (one, two, 
three urines)  
 
Reference standard: Kato-Katz (one, two, 
three stools, 41.7 mg triplicate) 
No, 
laboratory 
Yes  Not reported  Yes  POC-CCA 
20 min 
 
Kato-Katz 
30 min 
14 Coulibaly 
2011-study 
220 
Cote 
d’Ivoire 
2010 1 130 Children 8-12 yrs 53.1% Index test: POC-CCA cassette (one, two, 
three urines)  
 
Reference standard: Kato-Katz (one, two, 
three stools, 41.7 mg triplicate) 
No, 
laboratory 
Yes  Not reported Yes  POC-CCA 
20 min 
 
Kato-Katz 
30 min 
15 Coulibaly 
2011-study 
320 
Cote 
d’Ivoire 
2010 1 170 Children 8-12 yrs 91.8% Index test: POC-CCA cassette (one, two, 
three urines)  
 
Reference standard: Kato-Katz (one, two, 
three stools, 41.7 mg triplicate) 
No, 
laboratory 
Yes  Not reported Yes  POC-CCA 
20 min 
 
Kato-Katz 
30 min 
16 Shane 
201142 
Kenya  2007 1 484 Children 1-15 yrs 38.8% Index test: Cassette POC-CCA reagent strip 
(one urine), SWAP-specific IgG ELISA, 
Carbon CCA (25 mL of urine) 
 
Reference standard: Kato-Katz (three stool, 
duplicate) 
No, 
laboratory 
 Not reported Yes  CCA strips 
40 min 
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Table 1 cont`d. 
 
Sr.  
No 
Study  Country  Trial 
conducted 
N* Sample 
size 
Characteristics 
of participants 
Endemicity **  Diagnostic criteria Diagnosis at 
POC? 
Trace as 
positive 
Cost of test Acceptabil
ity of test 
Time for CCA 
preparation 
17 Sousa-
Figueiredo 
201043 
Uganda  Survey in 
Lake 
Albert 
area 2007 
and Lake 
Victoria 
2009 
Not 
reported 
608 (245 
mothers 
and 363 
children) 
 
Preschool 
children 
≤6 yrs, mothers 
In mothers 
(29.2% in Lake 
Victoria and 60% 
in Lake Albert) 
 
In children (16% 
in Lake Victoria 
and 43.3% in 
Lake Albert) 
Index test: POC-CCA cassette (one urine) 
 
Single SEA-ELISA (fingerprick blood (∼50 
μl)), four slides of Kato-Katz  
 
Reference standard: Kato-Katz (two stools, 
duplicate) 
 
Gold standard: Combined CCA (one urine 
50μl aliquot) and Kato–Katz (two stools, 41.7 
mg duplicate).  
No, 
laboratory 
Yes  £1.60 for CCA Yes  POC-CCA  
20 min 
18 Speich 20104  Tanzania 2009 2 1,066 School children 
6-20 yrs 
 Kato-Katz (one stool, 41.7 mg duplicate) No, 
laboratory 
N/A Single Kato-
Katz US$1.73 
and duplicate 
US$2.06 
Not 
reported  
Kato-Katz 20-40 min 
19 Standley 
201044 
Kenya, 
Tanzania  
2009 11 171 School children 
6-17 yrs 
68.6%? Index test: POC-CCA urine-dipstick (reagent 
strips) 
 
Reference standard: Kato-Katz (one stool, 
41.7 mg duplicate) 
Yes  Yes  $ 2.3-2.8 USD 
per dipstick 
Yes  Not reported 
20 Midzi 
200949 
Zimbabwe  2006 1 265 Pre- and school 
children 2-19 yrs 
40.4% Index test: Urine CCA reagent strips (25 mL 
of urine), Kato-Katz (one stool) and standard 
urine filtration (two consecutive days) 
 
Reference standard (gold standard): 
combined CCA and urine filtration 
Yes, plus 
laboratory  
CCA scored 
as weak +ve 
or strong 
+ve 
Not reported  Yes  CCA strips 
30 min 
21 Stothard 
200946 
Uganda  2009 1 242 Infants and 
preschool 
children ≤5 yrs 
>50% Index test: urine-based POC-CCA reagent 
strip; 75 μl for IEDM-ELISA (indirect egg 
detection method)  
 
Reference standard: Kato-Katz (two stools, 
41.7 mg duplicate) 
Yes  Not reported Cost prediction Yes  Not reported   
22 Ayele 
200836 
Ethiopia Not 
reported  
1 206 School children 4 
– 21 yrs 
47.6% Index test: POC-CCA reagent strip 
 
Reference standard: Urine filtration technique 
(10 mL urine) 
Yes  Not reported  CCA strip test, 
UD$4.95 
Yes  CCA 25 min 
23 Legesse 
200841 
Ethiopia  2007 1 184 School children 
5-22 yrs 
36.4% Index test: CCA reagent strip, Kato-Katz (one 
stool, duplicate slides) and Formol-ether 
concentration 
 
Reference standard: Kato-Katz (41.7 mg) 
Yes  CCA scored as 
weak +ve or 
strong +ve 
Not reported  Yes  Not reported  
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Table 1 cont`d. 
Sr.  
No 
Study  Country  Trial 
conducted 
N* Sample size Characteristics 
of participants 
Endemicity **  Diagnostic criteria Diagnosis at 
POC? 
Trace as 
positive 
Cost of test Acceptabil
ity of test 
Time for CCA 
preparation 
24 Legesse 
200740 
Ethiopia 2007 1 251 Whole population  
(adults and 
children >5 yrs)  
90% in school 
children 
Index test: CCA urine assays (25 mL of 
urine), Kato-Katz (one stool, duplicate slides) 
and Formol-ether concentration 
 
Reference standard: Kato-Katz (one stool, 
duplicate slides)  
No, 
laboratory  
CCA scored 
as weak +ve 
or strong +ve 
Not reported Not 
reported  
Not reported  
25 De Clercq 
1997a57 
Mali Not reported  2 Not stated 
(337 urine, 
352 serum 
and 134 
stool) 
Whole population 
(adults and 
children) in 
irrigation area  
99% Index test: CAA- ELISA; CCA-ELISA (5 ml 
of blood); 2-fold dilution series of urine (1 
ml) 
 
Reference standard: Kato-Katz (two stools, 
41.6 mg duplicate) 
No, 
laboratory 
Not reported Not reported  Yes  Not reported  
26 De Clercq 
1997b58 
Mali 1993  4 Not stated 
(431 urine, 
324 stool; 
348 blood) 
Whole population 
of adults and 
children  
Not reported  Index test: CAA- ELISA (1 ml urine and 5 ml 
of blood); CCA-ELISA (1 ml urine and 5 ml 
of blood); urine filtration (10 ml); one Kato-
Katz slide (41.6 mg) 
 
Reference standard: combined Kato-Katz 
(41.6 mg) and CAA-ELISA (1 ml urine and 5 
ml of blood)  
 
No, 
laboratory 
Not reported Not reported  Yes  Not reported  
27 Kremsner 
199417 
Cameroon  Not reported  1 148  School children 
4–13 yrs 
Not reported  Index test: CAA- EIA (urine and serum); 
CCA-EIA (urine and serum); thick blood 
smear (malarial parasites); combined reagent 
strip index (RSI)  
 
Reference standard: Kato-Katz, three (3) 
urine filtrations (10-50 ml) 
No, 
laboratory 
Not reported  Not reported  Yes  Not reported  
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Table 2a. Tests classified as Latent Class 1 
Study ID Index Test Reference Standard 
Coulibaly2011 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Coulibaly2011-study1 POC-CCA cassette (one urine) Kato-Katz (three stools) 
Coulibaly2011-study1 POC-CCA cassette (three urines) Kato-Katz (three stools) 
Coulibaly2011-study2 POC-CCA cassette (one urine) Kato-Katz (three stools) 
Coulibaly2011-study2 POC-CCA cassette (three urines) Kato-Katz (three stools) 
Coulibaly2011-study3 POC-CCA cassette (one urine) Kato-Katz (three stools) 
Koukounari2013-study2 POC-CCA cassette (one urine) Kato-Katz (three stools) 
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Table 2b. Tests classified as Latent Class 2 
 
Study ID Index Test Reference Standard 
Adriko2014 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Adriko2014 POC-CCA cassette (one urine) Kato-Katz (three stools) 
Coulibaly2011-study3 POC-CCA cassette (three urines) Kato-Katz (three stools) 
Coulibaly2013 POC-CCA cassette (one urine) Kato-Katz (three stools) 
Coulibaly2013 POC-CCA cassette (two urines) Kato-Katz (two stools) 
Dawson2013 POC-CCA cassette (one urine) Kato-Katz (two stools) 
Erko2013 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Erko2013 POC-CCA cassette (one urine) Kato-Katz (three stools) 
Erko2013 POC-CCA cassette (three urines) Kato-Katz (three stools) 
Koukounari2013-study1 POC-CCA cassette (one urine) Kato-Katz (three stools) 
Legesse2007 POC-CCA cassette (one urine) 
Kato-Katz  
(one stool plus formol ether concentration) 
Legesse2008 POC-CCA reagent (one urine) 
Kato-Katz  
(one stool plus formol ether concentration) 
Shane2011 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Sousa-Figueiredo2013 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Sousa-Figueiredo2013-study1 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Sousa-Figueiredo2013-study2 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Sousa-Figueiredo2013-study3 POC-CCA cassette (one urine) Kato-Katz (one stool) 
Standley2010 POC-CCA cassette (one urine) Kato-Katz (one stool) 
TchuemTchuente2012 POC-CCA cassette (one urine) Kato-Katz (one stool) 
TchuemTchuente2012-study1 POC-CCA cassette (one urine) Kato-Katz (three stools) 
TchuemTchuente2012-study1 POC-CCA cassette (three urines) Kato-Katz (three stools) 
TchuemTchuente2012-study2 POC-CCA  cassette(one urine) Kato-Katz (three stools) 
TchuemTchuente2012-study2 POC-CCA cassette (three urines) Kato-Katz (three stools) 
TchuemTchuente2012-study3 POC-CCA cassette (one urine) Kato-Katz (three stools) 
TchuemTchuente2012-study3 POC-CCA cassette (three urines) Kato-Katz (three stools) 
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Fig. 1. Flow diagram of the study selection process 
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Fig. 2a. Diagnostic accuracy of single POC-CCA versus single Kato-Katz as reference standard 
for the detection of S. mansoni infection 
 
For POC-CCA, trace was considered as positive. 
Kato-Katz consisted of single stool of duplicate slides (41.7mg of stool sample each). 
Data points for two studies21,24 were extracted from another study22 that reported primary data from a multi-country study in 
Africa. 
Two of the studies42,44 did not use POC-CCA cassettes but reagent strips that preceded the cassette formulation. 
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Fig. 2b. Diagnostic accuracy of single POC-CCA versus single Kato-Katz reference standard for the 
detection of S. mansoni infection from SROC curve 
 
 
For POC-CCA, trace was considered as positive. 
Kato-Katz consisted of single stool with duplicate slides (41.7mg of stool sample each). 
Data points for two studies21,24 were extracted from another study22 that reported primary data from a multi-country study in 
Africa. 
Two studies42,44 did not use POC-CCA cassettes but reagent strips that preceded the cassette formulation. 
 
Explaining the SROC curve 
The SROC curves presented here are information rich, and contain a number of graphical features that each needs to be 
understood.  The graph contains six separate types of information, represented by six separate types of graphical feature. 
Hollow circles represent the point estimates for the joint sensitivity and specificity of each individual study. Each of these 
hollow circles is surrounded by a light grey oval, which presents the 95% credible region associated with that particular study 
in ROC space. Similarly, the summary models, produced by pooling the estimates from each of the studies using a standard 
bivariate model, are presented both as a point estimate, represented by a solid black circle, and an associated 95% credible 
region, represented by the solid black line. In addition to this, the best estimate for how the sensitivity and specificity vary 
with the diagnostic threshold adopted is represented by a line which runs from the bottom left to the top right portion of the 
graph. The solid section of this line represents interpolated estimates, which ‘fill in the gaps’ between the studies available, 
whereas the dashed parts of this line are extrapolated from the data, and as such are more dependent on the modelling 
assumptions. Both the interpolated and the extrapolated parts of this line are needed in order to estimate the area under the 
curve (AUC), which is defined in the bottom right hand corner of the graph. 
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Fig. 2c. Single POC-CCA test versus three Kato-Katz tests for the detection of S. mansoni 
infection
 
Kato-Katz consisted of three consecutive stools of duplicate slides each of 41.7 mg. 
One of the studies32 used Kato-Katz from two consecutive stools. 
While other two of the studies40,41 used an older version of POC-CCA reagent strips (manufactured by European Vertinary 
Laboratory, Woerden, Holland) and compared with combined Kato-Katz and Formal Ether concentration test as reference 
standard. 
All other studies used POC-CCA cassette test (manufacturer: Rapid Medical Diagnostics, Pretoria, South Africa). Two stud-
ies published in one paper39 involved separate data for children (7-16 years) and adults (≥ 17 years) so we reported them as 
independent studies in the analysis. 
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Fig. 2d. Three POC-CCA tests versus Kato-Katz from three consecutive stools for the detection 
of S. mansoni infection  
 
 
One study47 used duplicate instead of three POC-CCA cassette tests, the rest assessed three POC-CCA tests; the same study 
also used two consecutive stools for Kato-Katz tests, the rest of the studies used three consecutive stools. 
For POC-CCA test, trace was considered as positive test. 
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Fig. 2e. Assessment of diagnostic accuracy between single and multiple POC-CCA and single 
and multiple Kato-Katz tests for the diagnosis of S. mansoni infection 
 
 
Studies included in this analysis had both index and reference tests examined in the same participants at the same time.  
Where a study assessed single, two, or three POC-CCA, the results of the single POC-CCA were selected for this analysis. 
Single POC-CCA test were chosen for the analysis from the three studies published in paper21 and another study from 
Ethiopia.38  
For POC-CCA test, trace was considered as positive.   
Where a study assessed single, two or three Kato-Katz, single Kato-Katz (duplicate 41.7 mg) was chosen as reference 
standard in conformity with what WHO recommends within the MDA/PC Strategy. Single Kato-Katz was selected for the 
analysis from the study by Erko 2013.38 
If different settings were involved in studies published in one article, the different settings were included as separate studies. 
Therefore, Coulibaly 201120 was classified as Coulibaly 2011 -study 1; Coulibaly 2011 -study 2; Coulibaly 2011 -study 3 and 
Tchuem Tchuente 201221 as Tchuem Tchuente 2012 -study 1; Tchuem Tchuente 2012 -study 2; Tchuem Tchuente 2012 -
study 3).  
Children and adults data reported separately were considered as separate datapoints in this analysis (Koukounari 201339). 
. 
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Fig. 3. Performance of POC-CCA strips versus standard 10 mL urine filtration for the diagnosis 
of urogenital schistosomiasis 
 
The study19 used reagent strips of POC-CCA with trace counted as positive test. 
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Fig. 4. LCBM showing Latent Classes of POC-CCA test 
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APPENDIX  
 
 
POC-CCA VERSUS KATO-KATZ 
 c) Three POC-CCA versus three Kato-Katz 
Eight studies, four from the same investigator from Cote d’Ivoire20, three from the same author from 
Cameroon21 and one from Ethiopia24  assessed the performance of three POC-CCA tests versus Kato-
Katz tests from three consecutive stools (duplicate 41.7 mg) for the detection of S. mansoni infection. 
The meta-analysis showed sensitivity of POC-CCA to be 0.91 [95% CI 0.84-0.95, n=8] and specificity 
0.56 [95% CI 0.39-0.72, n=8] (Fig. 5). Sensitivities showed to be fairly consistent across studies but 
specificities showed wide CIs and variability across studies.  
 
d) POC-CCA versus combined POC-CCA/Kato-Katz  
Only one study24 has investigated POC-CCA versus POC-CCA/Kato-Katz combined as reference 
standard for the diagnosis of S. mansoni infection and showed sensitivity of POC-CCA to be high 
(90%) with no false positives detected, giving a specificity of 100% (Table not shown). When the 
number of the index POC-CCA test was increased to three consecutive test, sensitivity increased to 
96% (only marginally over single POC-CCA) and specificity remained unchanged (100%). The results 
should be treated with caution though as it came from only one study. 
 
e) Global performance of POC-CCA versus Kato-Katz  
Nineteen studies were combined in the meta-analysis for the assessment of single and multiple POC-
CCA (up to three tests) versus single and multiple Kato-Katz (up to three tests) for the diagnosis of S. 
mansoni infection and the results showed pooled sensitivity and specificity of 0.85 [95% CI 0.80-0.88, 
n=9] and 0.60 [95% CI 0.50-0.69, n=9], respectively. CIs of most of the study estimates were wide 
reflecting possible small sample sizes. Sensitivities showed to be fairly consistent across studies, but 
specificities showed a considerable degree of variability across studies (Fig. 7). 
 
POC-CCA REAGENT STRIP VERSUS 10 ML URINE FILTRATION TEST 
The performance of POC-CCA was assessed for the detection of S. haematobium infection in two 
stuides in Ethiopia and Zimbabwe with mixed results: pooled sensitivity [0.66, 95% CI 0.37-0.87, 
n=2] and pooled specificity [0.54, 95% CI 0.34-0.73, n=2].  Given that only two studies were involved 
in the meta-analysis, the studies were conducted before 2007 and used relatively older version of 
POC-CCA reagent strips develped by the European Vertinary Laboratory, Woerden, Holland, the 
results should be treated with some caution.  . In the study from Zimbabwe49 when  CCA was 
compared with combined CCA/urine filtration as reference standard, the results showed an 
improvement in sensitivity of CCA by about 10% from 79% to 88.2%. Similarly, accuracy of CCA 
test assessed from SROC curve showed low performanace from AUC curve (0.62, Fig. 3). 
 
THE EFFECT OF ENDEMICITY, THRESHOLD AND AGE ON PERFORMANCE 
OF POC-CCA  
a) Background endemicity  
Four studies20,21,23,24 assessed the effect of endemicity (low versus moderate-to-high) on diagnostic 
performance of POC-CCA in a meta-analysis and showed sensitivity for low endemicity was 0.69 
[95% CI 0.56-0.79] and specificity 0.78 [95% CI 0.54-0.91], with  somehow wide CIs , particularly 
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for specificity. Moderate to high endemicity showed relatively higher pooled sensitivity [0.81, 95% CI 
0.76-0.85] and specificity [0.74, 95% CI 0.55-0.87], with sensitivities consistent across studies. 
Specificities showed somehow wide CIs around their effect estimates (Fig. not shown). The diagnostic 
accuracy as measured by AUC under the ROC space was 0.76 (Fig. not shown). 
b) Threshold  
The four studies conducted between 2009 and 2011, two from Uganda23,24 one from a village along the 
Tanzanian-Kenyan border44 and one study from Cote d’Ivoire47 assessed the impact of POC-CCA test 
when trace was considered as positive for the diagnosis of S. mansoni infection. The studies showed 
an overall high sensitivity [0.93, 95% CI 0.74-0.99] but very low specificity [0.42, 95% CI 0.28-0.58]. 
Except the study by Sousa-Figueiredo 201323, sensitivities appeared to be consistent across studies.  
Although the pooled specificity was low, one study44 reported unusually low specificity [0.19, 95% CI 
0.10-0.33], but this is not expected to have affected the magnitude of the overall specificity as the 
weight contributed by the study was very small weight. Accuracy as measured by AUC under the 
ROC space was low 0.66 although the ROC curves and AUC estimates seem model dependent. 
Considering trace of POC-CCA test as negative decreased sensitivity by about 18% to 0.75 [95% CI 
0.58-0.86, n=4] but improved specificity by about 37% to 0.79 [95% CI 0.73-0.85]. The study from 
the Kenya-Tanzania shoreline district of Lake Victoria44 showed the biggest variation in both 
sensitivity and specificity. 
 
c) Age  
Only one study39 involving children aged 7-16 years versus adults 17-76 years has assessed the impact 
of age on accuracy of POC-CCA using Kato-Katz test (two stools, 41.7 mg duplicate) as reference 
standard. The results showed that sensitivity (82%) and specificity (84%) were high for adults (Table 
not shown). When POC-CCA was assessed in children, sensitivity improved by about 8% to 90% but 
specificity decreased considerably to 50%.  The results should be treated with caution though as it 
came from only one study with limited sample size. 
 
SENSITIVITY ANALYSIS 
We conducted sensitivity analyses to explore the effect of leaving a study from each of the analyses on 
the pooled AUCs which indicated that most analyses were not strongly influenced by any one 
particular study, with the exception of one study20 in Analysis 1, whose exclusion reduced pooled 
AUC by -0.129 (around 15%); Tchuem Tchuente (2012)21 in Analysis 6, whose exclusion reduced the 
pooled AUC by 0.091 (around 8%); and Sousa-Figueiredo (2013)23 in Analysis 8, whose exclusion 
increased the pooled AUC by 0.069 (around 11%) (Figures not provided). 
 
LATENT CLASS BIVARIATE ANALYSIS OF POC-CCA TEST 
We applied an exploratory latent analysis34 to investigate the performance of POC-CCA test with 
Kato-Katz as reference standard. Two latent classes have been identified using AIC with a substantial 
difference in specificity. The clustering of studies in two latent classes leads to conclude that the data 
showed substantial heterogeneity, suggesting that the observed variation of test outcomes cannot be 
explained by threshold effect alone. Latent Class 1 showed mean sensitivity of 76.4% [95% CI 72.3%-
80.5%] and mean specificity of 84.2% [95% CI 79.9%-88.5%]. Latent Class 2 shows mean sensitivity 
of 89.6% [95% CI 88.0%-91.2%] and specificity of 47.1% [95% CI 43.2%-50.9%]. Hence, studies in 
the Latent Class 1 show a better performance (higher specificity at the price of small loss in 
sensitivity).  Studies that used CCA versus combined CCA/KK tests were not inclued in the LCA. 
 
31 
 
From the output of the LCBM, urine samples do not appear to be related to the probability of a study 
being classified in a particular latent class thus increasing the number of urine samples do not result in 
a significant increase in test performance (Table 2a and Table 2b). The same holds for the number of 
stools in the Kato-Katz reference standard which was tested in the LCBM with the number of urine 
samples and stools as covariates, resulting in non-significant estimates. Sensitivities and specificities 
of studies classified in the two Latent Classes are plotted on the ROC space (Fig. 8). 
 
ACCEPTABILITY OF POC-CCA TEST 
Majority of participants in the studies that investigated acceptability stated that they considered the 
urine-based POC-CCA test as convenient and acceptable (21 out of 21 studies). The remaining six 
studies did not investigate this outcome (see Table 1). Still, there is paucity of comparative 
information on acceptability between POC-CCA and Kato-Katz tests.  
 
COST OF TESTING 
The study revealed paucity of information on cost of POC-CCA and Kato-Katz testing. Data from six 
studies showed that on average a single CCA will cost around US$ 1.70 for the diagnosis of 
schistosome infections, which is the same for a single Kato-Katz (US$1.70). The evidence presented 
should be treated with caution as the data appeared to have been quoted without formal cost analysis 
(Table 1). There are uncertainties about the prices of CCA but anecdotal data indicate that the price of 
CCA which is currently expensive and may not be met with national budget of countries in resource-
limited settings, the price can be brought down to less than that of Kato-Katz depending on the 
quantity of kits purchased. 
  
TIME FOR PREPARING TEST 
Eleven studies reported time taken to prepare POC-CCA and Kato-Katz and showed that it took 5-25 
minutes to prepare POC-CCA compared to 30-60 minutes for Kato-Katz test (Table 1). The older ver-
sion of POC-CCA (CCA strips) took relatively longer time (40 minutes), but this is no longer in use. 
